Overview

Update
Status
Acquired by on November 18, 2015
IPO / Stock
Went Public on Jan 31, 2014 / NASDAQ:CLDN
Headquarters:
La Jolla, California
Description:
Celladon is a biotechnology company developing molecular therapies for the treatment of heart failure.
Founders:
Categories:
Therapeutics, Biotechnology, Hospital
Website:
http://www.celladon.net
Social:

Company Details

Update

Celladon Corporation, a biotechnology company, develops and manufactures molecular therapies for the treatment of heart failure. Its products include SERCA2a, an enzyme that regulates calcium cycling and contractility in heart muscle cells; and MYDICAR, an enzyme replacement therapy for heart failure. Celladon was founded in 2000 and is based in La Jolla, California.

Funding Rounds (12) - $172.01M

Update
DateAmount / RoundValuationLead InvestorInvestors
Nov, 2015$39.5M / Post Ipo Equity6
Oct, 2013$1.1M / Debt Financing0
May, 2012$19.47M / Venture0
May, 2012$10M / Venture1
Feb, 2012$43M / Venture6
Dec, 2011$500k / Debt Financing0
Sep, 2011$250k / Debt Financing0
Jul, 2011$400k / Debt Financing0
Oct, 2010$2.5M / Debt Financing0
Dec, 2009$3.5M / Debt Financing0
Nov, 2009$21.8M / Series C3
Dec, 2005$30M / Series B4

Current Team (1)

Update

Offices/Locations (2)

Update
  • Headquarters

    2223 Avenida de la Playa

    Suite 300

    La Jolla, California 92037

    United States

  • San Diego Office

    11988 El Camino Real

    Suite 650

    San Diego, California 92130-3579

    United States

Past Team (1)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos